| NCT ID | NCT04160533 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation |
| Condition | Arterial Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,400 participants |
| Start Date | 2018-06-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,400 participants in total. It began in 2018-06-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population. The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations. The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice. Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.
Eligibility Criteria
Inclusion Criteria: The diagnosis of arterial hypertension - Exclusion Criteria: No diagnosis of arterial hypertension \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04160533 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Arterial Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04160533 currently recruiting?
Yes, NCT04160533 is actively recruiting participants. Contact the research team at aksenovaannav@gmail.com for enrollment information.
Where is the NCT04160533 trial being conducted?
This trial is being conducted at Moscow, Russia, Engel's, Russia, Engel's, Russia, Kemerovo, Russia and 11 additional locations.
Who is sponsoring the NCT04160533 clinical trial?
NCT04160533 is sponsored by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation. The trial plans to enroll 10,400 participants.